|
시장보고서
상품코드
2024448
단일 세포 멀티오믹스 시장 보고서 : 유형, 제품 유형, 방법, 용도, 최종사용자, 지역별(2026-2034년)Single Cell Multiomics Market Report by Type, Product Type, Technique, Application, End User, and Region 2026-2034 |
||||||
세계의 단일 세포 멀티오믹스 시장 규모는 2025년에 53억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 177억 달러에 달하며, 2026-2034년에 CAGR 14.02%로 성장할 것으로 예측하고 있습니다.
단일세포 멀티오믹스는 개별 세포에서 여러 유형의 분자를 분석하여 세포의 다양성과 불균일성에 대한 지식을 얻는 것을 말합니다. 여기에는 단일세포유전체학, 단백질체학, 전사체학, 대사체학이 포함되며, 신경학, 면역학, 세포생물학, 종양학 등에서 널리 활용되고 있습니다. 단일세포 멀티오믹스는 불균일한 조직의 집단 구조와 세포 특성을 이해하는 데 도움이 됩니다. 이 기술은 단일 세포 분리 및 분주 기술을 활용하여 분자 수준 및 복잡한 생물학적 구조의 이미지를 제공합니다. 기존 생세포 형광 이미징 기술에 비해 단일 세포 멀티오믹스는 분석을 위해 세포를 파괴할 필요가 없으며, 단일 세포에서 여러 유형의 분자를 측정할 수 있습니다. 그 결과, 생명공학 기업, 제약회사, 병원, 학술기관 및 연구기관, 진단검사실 등에서 널리 활용되고 있습니다.
단일 세포 멀티오믹스 시장 동향:
암 및 전염성 바이러스 질환과 같은 만성질환의 유병률 증가는 시장 성장을 이끄는 주요 요인 중 하나입니다. 단일세포 멀티오믹스는 종양내 세포 성분에 대한 고해상도 전체상을 제공합니다. 또한 세포의 이질성, 종양 미세환경의 시각화 및 분석, 항체 개발을 위한 제품의 보급이 시장 성장을 촉진하고 있습니다. 또한 데옥시리보핵산(DNA), 메신저리보핵산(mRNA) 및 단백질 프로파일을 단일 세포 수준에서 측정할 수 있는 단일 세포 분리 기술 및 바코딩 기술 개발 등 다양한 기술 발전이 시장 성장에 박차를 가하고 있습니다. 이에 따라 제약 산업의 괄목할 만한 성장이 시장 성장에 긍정적인 영향을 미치고 있습니다. 또한 유전성 질환 치료에 있으며, 개인맞춤형 의료의 도입 확대, 헬스케어 인프라의 대폭적인 개선 등 다른 요인들도 시장 성장을 촉진할 것으로 예상됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 단일 세포 멀티오믹스 시장
제6장 시장 내역 : 유형별
제7장 시장 내역 : 제품 유형별
제8장 시장 내역 : 방법별
제9장 시장 내역 : 용도별
제10장 시장 내역 : 최종사용자별
제11장 시장 내역 : 지역별
제12장 SWOT 분석
제13장 밸류체인 분석
제14장 Porters Five Forces 분석
제15장 가격 분석
제16장 경쟁 구도
KSA 26.05.14The global single cell multiomics market size reached USD 5.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 17.7 Billion by 2034, exhibiting a growth rate (CAGR) of 14.02% during 2026-2034.
Single cell multiomics refers to the analysis of multiple types of molecules from an individual cell to gain insights regarding cellular diversity and heterogenity. It involves single cell genomics, proteomics, transcriptomics and metabolomics and is widely used in neurology, immunology, cell biology and oncology. Single cell multiomics aids in enhancing the understanding of population architectures and cellular properties of heterogeneous tissues. It utilizes single cell isolation and dispensing techniques to provide images of the molecular layers and complex biological structures. In comparison to the traditionally used live-cell fluorescence imaging techniques, single-cell multi-omics does not involve the destruction of cells for analysis and can measure multiple types of the molecule from a single cell. As a result, it is widely used across biotechnology and pharmaceutical organizations, hospitals, academics and research institutes and diagnostic laboratories.
SINGLE CELL MULTIOMICS MARKET TRENDS:
The rising prevalence of chronic diseases, such as cancer and communicable viral diseases, is one of the key factors driving the growth of the market. Single cell multiomics provides a high-resolution landscape of cellular components in the tumors. Additionally, the widespread product adoption for visualization and analysis of cell heterogeneity, tumor micro-environment and antibody development are favoring the market growth. Moreover, various technological advancements, such as the development of single-cell isolation and barcoding technologies that enable deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA) and protein profiles to be measured at a single-cell resolution, are providing a thrust to the market growth. In line with this, significant growth in the pharmaceutical industry is positively impacting the market growth. Other factors, including the increasing adoption of personalized medicine for the treatment of genetic disorders, along with the extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
KEY MARKET SEGMENTATION:
Breakup by Type:
- Single Cell Genomics
- Single Cell Proteomics
- Single Cell Transcriptomics
- Single Cell Metabolomics
Breakup by Product Type:
- Consumables
- Instruments
- Software
Breakup by Technique:
- Single-Cell Isolation and Dispensing
- Single-Cell Analysis
Breakup by Application:
- Oncology
- Cell Biology
- Neurology
- Others
Breakup by End User:
- Academic Institutes
- Contract Research Organizations
- Pharmaceutical and Biotech Companies
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report provides a comprehensive analysis of the competitive landscape in the global single cell multiomics market with detailed profiles of all major companies, including:
- 10x Genomics
- Becton, Dickinson and Company
- BGI
- Bio-Rad Laboratories, Inc
- Bruker Spatial Biology, Inc.
- Illumina, Inc.
- Miltenyi Biotec
- Mission Bio
- NanoCellect Biomedical
- Qiagen N.V.
- Standard BioTools
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Single Cell Multiomics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Single Cell Genomics
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Single Cell Proteomics
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Single Cell Transcriptomics
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Single Cell Metabolomics
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Product Type
- 7.1 Consumables
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Instruments
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Software
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Technique
- 8.1 Single-Cell Isolation and Dispensing
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Single-Cell Analysis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Application
- 9.1 Oncology
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Cell Biology
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Neurology
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by End User
- 10.1 Academic Institutes
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Contract Research Organizations
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Pharmaceutical and Biotech Companies
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 10x Genomics
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.2 Becton, Dickinson and Company
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 BGI
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.4 Bio-Rad Laboratories, Inc.
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.4.4 SWOT Analysis
- 16.3.5 Bruker Spatial Biology, Inc.
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 Illumina, Inc.
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 Financials
- 16.3.6.4 SWOT Analysis
- 16.3.7 Miltenyi Biotec
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 Mission Bio
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.9 NanoCellect Biomedical
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.10 Qiagen N.V.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.10.4 SWOT Analysis
- 16.3.11 Standard BioTools
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 Financials
- 16.3.11.4 SWOT Analysis
- 16.3.12 Takara Bio Inc.
- 16.3.12.1 Company Overview
- 16.3.12.2 Product Portfolio
- 16.3.12.3 Financials
- 16.3.13 Thermo Fisher Scientific Inc.
- 16.3.13.1 Company Overview
- 16.3.13.2 Product Portfolio
- 16.3.13.3 Financials
- 16.3.13.4 SWOT Analysis
- 16.3.1 10x Genomics
